Effective antidiabetic and antioxidant fractions of Otostegia persica extract and their constituents

Pharm Biol. 2014 Aug;52(8):961-6. doi: 10.3109/13880209.2013.874463. Epub 2014 Feb 20.

Abstract

Context: Otostegia persica (Burm.) Boiss. (Lamiaceae), "Goldar" in Persian, is widely used in the folk medicine of south Iran for control of diabetes mellitus.

Objective: In the present study, hypoglycemic and antioxidant effects of different fractions of the O. persica extract were investigated and constituents of effective fractions were elucidated.

Materials and method: Different concentrations (100-400 mg/kg) of aqueous infusion (AI) of flowering aerial parts of the plant (traditional preparation) and all fractions of the O. persica extract (i.p. injection) were tested for antidiabetic activity in streptozocin-induced diabetic NMRI mice. Blood glucose level was measured at time 0 and intervals of 1, 2, 4, and 6 h later. Antioxidant activities of different fractions of the plant extract and pure compounds (0.1, 0.5, and 1 mg/ml) were determined with the DPPH method. Four compounds were isolated and identified from potent fractions.

Results and discussion: Antidiabetic activity demonstrated that the effect of the methanol fraction at a dose of 300 mg/kg was equivalent with glibenclamide, and at a dose of 400 mg/kg was comparable with glibenclamide and insulin (p > 0.05). The EC50 of the methanol fraction was 307.12 mg. Methanol and ethyl acetate fractions showed antioxidant activities (both IC50 equal to 0.49 mg/ml), so these fractions were selected for the purification of compounds. Chrysoeriol from ethyl acetate and three apigenin derivatives (6-methylapigenin, apigenin-7-O-glucoside, and echinaticin) from the methanol fraction were isolated and identified (new for the species). Chrysoeriol exhibited potent antioxidant activity comparable with vitamin E and BHT (p > 0.05).

Conclusion: The present study confirmed the folklore usage of O. persica for antidiabetic properties.

Keywords: Apigenin derivatives; chrysoeriol; hypoglycemic effect; radical scavenging activity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antioxidants / chemistry
  • Antioxidants / isolation & purification
  • Antioxidants / therapeutic use*
  • Diabetes Mellitus, Experimental / drug therapy*
  • Diabetes Mellitus, Experimental / metabolism
  • Hypoglycemic Agents / chemistry
  • Hypoglycemic Agents / isolation & purification
  • Hypoglycemic Agents / therapeutic use*
  • Lamiaceae*
  • Male
  • Mice
  • Plant Components, Aerial
  • Plant Extracts / chemistry
  • Plant Extracts / isolation & purification
  • Plant Extracts / therapeutic use*
  • Treatment Outcome

Substances

  • Antioxidants
  • Hypoglycemic Agents
  • Plant Extracts